Universe Pharmaceuticals (UPC) Short term Debt (2020 - 2024)

Historic Short term Debt for Universe Pharmaceuticals (UPC) over the last 6 years, with Q3 2025 value amounting to $446.5 billion.

  • Universe Pharmaceuticals' Short term Debt fell 9352.89% to $446.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $446.5 billion, marking a year-over-year decrease of 9352.89%. This contributed to the annual value of $446.5 billion for FY2025, which is 9352.89% down from last year.
  • Per Universe Pharmaceuticals' latest filing, its Short term Debt stood at $446.5 billion for Q3 2025, which was down 9352.89% from $6900.6 billion recorded in Q3 2024.
  • In the past 5 years, Universe Pharmaceuticals' Short term Debt ranged from a high of $6900.6 billion in Q3 2024 and a low of $7293.0 during Q1 2022
  • Moreover, its 5-year median value for Short term Debt was $5.5 million (2023), whereas its average is $918.4 billion.
  • In the last 5 years, Universe Pharmaceuticals' Short term Debt crashed by 10000.0% in 2021 and then surged by 12586655538.22% in 2024.
  • Universe Pharmaceuticals' Short term Debt (Quarter) stood at $19723.0 in 2021, then soared by 17033.62% to $3.4 million in 2022, then surged by 62.24% to $5.5 million in 2023, then soared by 125866555.38% to $6900.6 billion in 2024, then crashed by 93.53% to $446.5 billion in 2025.
  • Its Short term Debt was $446.5 billion in Q3 2025, compared to $6900.6 billion in Q3 2024 and $5.5 million in Q1 2024.